Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Hanley

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Blood Transfusion = Trasfusione Del Sangue|August 9, 2021
Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte culturesChristopher A Lazarski, Keri Toner, Michael D Keller, et al.
Brain, Behavior, and Immunity|May 21, 2013
The effects of age and latent cytomegalovirus infection on the redeployment of CD8+ T cell subsets in response to acute exercise in humansGuillaume Spielmann, Catherine M Bollard, Austin B Bigley, et al.
Molecular Therapy. Methods & Clinical Development|May 9, 2017
Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord BloodHema Dave, Min Luo, J W Blaney, et al.
The Annals of Thoracic Surgery|September 30, 2019
Impact of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass on Postnatal NeurogenesisTakuya Maeda, Kamil Sarkislali, Camille Leonetti, et al.
Cytotherapy|June 23, 2020
Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapiesMaria Cancio, Rachele Ciccocioppo, Patricia R M Rocco, et al.
Cytotherapy|June 30, 2024
Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital settingJay Tanna, Chase D McCann, Rhonda Smith, et al.
Pediatric Blood & Cancer|December 19, 2019
EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defectsJeremy D Rubinstein, Karen Burns, Michael Absalon, et al.
Cytotherapy|November 19, 2016
Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvantsKaushik Parsha, Osman Mir, Nikunj Satani, et al.
Frontiers in Oncology|April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against CancerShabnum Patel, Rachel A Burga, Allison B Powell, et al.
Cytotherapy|October 1, 2015
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potencyBahey Salem, Samantha Miner, Nancy F Hensel, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Blood Transfusion = Trasfusione Del Sangue|August 9, 2021
Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte culturesChristopher A Lazarski, Keri Toner, Michael D Keller, et al.
Brain, Behavior, and Immunity|May 21, 2013
The effects of age and latent cytomegalovirus infection on the redeployment of CD8+ T cell subsets in response to acute exercise in humansGuillaume Spielmann, Catherine M Bollard, Austin B Bigley, et al.
Molecular Therapy. Methods & Clinical Development|May 9, 2017
Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord BloodHema Dave, Min Luo, J W Blaney, et al.
The Annals of Thoracic Surgery|September 30, 2019
Impact of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass on Postnatal NeurogenesisTakuya Maeda, Kamil Sarkislali, Camille Leonetti, et al.
Cytotherapy|June 23, 2020
Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapiesMaria Cancio, Rachele Ciccocioppo, Patricia R M Rocco, et al.
Cytotherapy|June 30, 2024
Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital settingJay Tanna, Chase D McCann, Rhonda Smith, et al.
Pediatric Blood & Cancer|December 19, 2019
EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defectsJeremy D Rubinstein, Karen Burns, Michael Absalon, et al.
Cytotherapy|November 19, 2016
Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvantsKaushik Parsha, Osman Mir, Nikunj Satani, et al.
Frontiers in Oncology|April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against CancerShabnum Patel, Rachel A Burga, Allison B Powell, et al.
Cytotherapy|October 1, 2015
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potencyBahey Salem, Samantha Miner, Nancy F Hensel, et al.
Pageof 10